Hepatitis A
Hepatitis A
AVAXIM · HAVRIX 1440 · HAVRIX 720 JUNIOR · VAQTA
Two doses, 6 or more months apart. Every product below is a Health Canada authorized vaccine; every schedule comes from the Canadian Immunization Guide.
Products authorized in Canada
Brand names and DINs (Drug Identification Numbers) as Health Canada's Drug Product Database lists them. The product monograph is the manufacturer's full prescribing information approved by Health Canada.
| Product | DIN | What it is | Presentation and age | Official information |
|---|---|---|---|---|
| AVAXIM | 02237792 | Hepatitis A virus, inactivated | 160 U / 0.5 mL · suspension · intramuscular · 12 years and older | Product guideHealth Canada recordProduct monograph (PDF) |
| HAVRIX 1440 | 02187078 | Hepatitis A virus, inactivated | 1440 U / 1 mL · suspension · intramuscular · 19 years and older | Product guideHealth Canada recordProduct monograph (PDF) |
| HAVRIX 720 JUNIOR | 02231056 | Hepatitis A virus, inactivated | 720 U / 0.5 mL · suspension · intramuscular · 6 months to 18 years | Product guideHealth Canada recordProduct monograph (PDF) |
| VAQTA | 02229702 | Hepatitis A vaccine, inactivated | 50 U / 1 mL · suspension · intramuscular · 18 years and older | Product guideHealth Canada recordProduct monograph (PDF) |
Pregnancy and breastfeeding
Pregnancy
Use if indicated: after an exposure, or for travel to an endemic area.
Breastfeeding
Use if indicated.
Source: Immunization in pregnancy and breastfeeding: Canadian Immunization Guide — Chapter updated August 2026. Live vaccines are generally contraindicated in pregnancy; routinely recommended vaccines can be given while breastfeeding unless the chapter says otherwise.
How many doses
The schedules the Canadian Immunization Guide describes for this vaccine. Which one applies depends on age, health and product — use the dose planner to see the dates for your situation.
| Schedule | Doses | Who it is for | Products |
|---|---|---|---|
| Hepatitis A — adult and adolescent two-dose series Two doses of hepatitis A vaccine, the second 6 to 36 months after the first depending on the product. | 2 doses | Adult products: HAVRIX 1440 for 19 years and older (dose 2 at 6 to 12 months), AVAXIM for 12 years and older (dose 2 at 6 to 36 months), VAQTA adult for 18 years and older (dose 2 at 6 to 18 months). One dose gives protective antibody in nearly all recipients; the second gives long-term protection. | HAVRIX 1440, AVAXIM, VAQTA |
| Hepatitis A — child two-dose series (6 months to 18 years) Two doses of paediatric hepatitis A vaccine, the second 6 to 12 months after the first. | 2 doses | HAVRIX 720 Junior is authorized from 6 months to less than 19 years of age. Publicly funded eligibility varies by province. The series is complete after the second dose. | HAVRIX 720 JUNIOR |
| Hepatitis A — weakened immune system, two doses Standard two-dose hepatitis A series; the response may be reduced. | 2 doses | Hepatitis A vaccine may be given to immunocompromised people; the response may be reduced but the vaccine still offers some protection. Immune globulin may be considered for pre- and post-exposure protection, and blood testing after immunization may be considered where available. | HAVRIX 1440, AVAXIM, VAQTA, HAVRIX 720 JUNIOR |
Sources
- Hepatitis A vaccines: Canadian Immunization Guide — Chapter revised March 2018
- Health Canada Drug Product Database — product records and monographs
Clinical rules reviewed on 2026-09-27. General information from public Canadian guidance; a personal assessment is needed for treatment decisions. Care365 does not decide whether a vaccine is publicly funded in Ontario.